| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.60▼ | 1.60▼ | 1.59▲ | 1.71▼ | 1.78▼ |
| MA10 | 1.60▼ | 1.60▼ | 1.58▲ | 1.81▼ | 1.86▼ |
| MA20 | 1.59▲ | 1.61▼ | 1.66▼ | 1.79▼ | 1.91▼ |
| MA50 | 1.68▼ | 1.72▼ | 1.79▼ | 1.91▼ | 1.82▼ |
| MA100 | 1.75▼ | 1.83▼ | 1.80▼ | 1.88▼ | 1.16▲ |
| MA200 | 1.84▼ | 1.81▼ | 1.84▼ | 2.05▼ | 1.41▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.006▲ | 0.007▲ | 0.004▲ | -0.021▼ | -0.052▼ |
| RSI | 45.208▼ | 43.312▼ | 43.232▼ | 42.417▼ | 45.188▼ |
| STOCH | 58.194 | 51.582 | 50.450 | 26.370 | 25.133 |
| WILL %R | -68.750 | -40.741 | -58.974 | -84.426▼ | -74.183 |
| CCI | -69.808 | 14.602 | -20.372 | -131.981▼ | -80.357 |
|
Wednesday, March 18, 2026 12:59 PM
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
|
|
Thursday, March 12, 2026 03:08 PM
Presented updated glioblastoma (“GBM”) data demonstrating durable survival and a favorable safety profile across Phase 1 and Phase 2 programs, with repeat dosing of DeltEx™ Drug-Resistant ...
|
|
Tuesday, February 24, 2026 12:00 AM
NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ) T cell therapies for cancer and autoimmune ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 25/03/26 | 1.61 | 1.65 | 1.57 | 1.595 | 182,111 |
| 24/03/26 | 1.655 | 1.67 | 1.50 | 1.55 | 91,083 |
| 23/03/26 | 2.00 | 2.00 | 1.58 | 1.66 | 239,684 |
| 20/03/26 | 1.70 | 2.03 | 1.70 | 2.00 | 254,382 |
| 19/03/26 | 1.79 | 1.84 | 1.70 | 1.72 | 36,773 |
| 18/03/26 | 1.86 | 1.977 | 1.7936 | 1.84 | 45,461 |
| 17/03/26 | 2.05 | 2.05 | 1.87 | 1.91 | 51,895 |
| 16/03/26 | 1.89 | 2.11 | 1.85 | 2.06 | 95,610 |
| 13/03/26 | 1.90 | 1.99 | 1.82 | 1.89 | 61,134 |
| 12/03/26 | 2.00 | 2.05 | 1.90 | 1.91 | 41,540 |
|
|
||||
|
|
||||
|
|